Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.

H, Fontaine; L, Alric; J, Labreuche; B, Legendre; A, Louvet; C, Antoine; CM, Legendre; M, Hazzan; N, Kamar; S, Dharancy; S, Pol; A, Duhamel; P, Mathurin

doi:10.1016/j.jhep.2018.12.036

Public

Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.

Shared by NobleBlocks on Mar 14, 2019 • 12:00 AM UTC

Authors:

Fontaine H

Alric L

Labreuche J

Abstract

Background & aims Before antiviral therapy, kidney transplant recipients infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) had poor outcomes. Since the 90s, nucleos(t)ide analogues have been widely used in HBV-infected patients, while interferon-based therapy was rarely used in HCV-in...

Subject

Prognosis

Chronic hepatitis C

chronic hepatitis B

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!